Truist Securities Reiterates Buy on Eli Lilly and Co, Raises Price Target to $1000
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has reiterated its Buy rating on Eli Lilly and Co (NYSE:LLY) and raised the price target from $892 to $1000.
June 25, 2024 | 1:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has reiterated its Buy rating on Eli Lilly and Co (NYSE:LLY) and raised the price target from $892 to $1000.
The reiteration of a Buy rating and an increased price target from a reputable analyst firm like Truist Securities is likely to positively impact investor sentiment and drive short-term price appreciation for Eli Lilly and Co.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100